Correcting Calcium Dysregulation in Chronic Heart Failure Using SERCA2a Gene Therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Correcting Calcium Dysregulation in Chronic Heart Failure Using SERCA2a Gene Therapy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 4, Pages 1086
Publisher
MDPI AG
Online
2018-04-06
DOI
10.3390/ijms19041086
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Benefit and Gene Network Regulation by Combined Gene Transfer of Apelin, FGF2, and SERCA2a into Ischemic Heart
- (2018) Edith Renaud-Gabardos et al. MOLECULAR THERAPY
- Doxycycline modulates VEGF-A expression: Failure of doxycycline-inducible lentivirus shRNA vector to knockdown VEGF-A expression in transgenic mice
- (2018) Mari Merentie et al. PLoS One
- Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial
- (2017) Jean-Sébastien Hulot et al. EUROPEAN JOURNAL OF HEART FAILURE
- Prevention of Atrial Fibrillation by Using Sarcoplasmic Reticulum Calcium ATPase Pump Overexpression in a Rabbit Model of Rapid Atrial Pacing
- (2017) Hong li Wang et al. MEDICAL SCIENCE MONITOR
- Gene therapy for the treatment of heart failure: promise postponed
- (2016) Jean-Sebastien Hulot et al. EUROPEAN HEART JOURNAL
- Risk factors for heart failure are associated with alterations of the LV end-diastolic pressure–volume relationship in non-heart failure individuals: data from a large-scale, population-based cohort
- (2016) Michael Schwarzl et al. EUROPEAN HEART JOURNAL
- Junctophilin-2 gene therapy rescues heart failure by normalizing RyR2-mediated Ca2+ release
- (2016) Julia O. Reynolds et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial
- (2016) Barry Greenberg et al. LANCET
- Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation
- (2015) Melvin Y. Rincon et al. CARDIOVASCULAR RESEARCH
- Efficacy and safety of myocardial gene transfer of adenovirus, adeno-associated virus and lentivirus vectors in the mouse heart
- (2015) M Merentie et al. GENE THERAPY
- Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure
- (2015) B Greenberg et al. GENE THERAPY
- Effect of SERCA2a overexpression in the pericardium mediated by the AAV1 gene transfer on rapid atrial pacing in rabbits
- (2015) B.N. Kuken et al. GENETICS AND MOLECULAR RESEARCH
- Gene Therapy for Heart Failure: Back to the Bench
- (2015) Seppo Ylä-Herttuala MOLECULAR THERAPY
- Atrial SERCA2a Overexpression Has No Affect on Cardiac Alternans but Promotes Arrhythmogenic SR Ca2+ Triggers
- (2015) Michelle M. J. Nassal et al. PLoS One
- Emerging roles of junctophilin-2 in the heart and implications for cardiac diseases
- (2014) David L. Beavers et al. CARDIOVASCULAR RESEARCH
- Microtubule-Mediated Defects in Junctophilin-2 Trafficking Contribute to Myocyte Transverse-Tubule Remodeling and Ca 2+ Handling Dysfunction in Heart Failure
- (2014) Caimei Zhang et al. CIRCULATION
- Safety and efficacy of high-dose adeno-associated virus 9 encoding sarcoplasmic reticulum Ca2+ adenosine triphosphatase delivered by molecular cardiac surgery with recirculating delivery in ovine ischemic cardiomyopathy
- (2014) Michael G. Katz et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Overexpression of junctophilin-2 does not enhance baseline function but attenuates heart failure development after cardiac stress
- (2014) A. Guo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Design of a Phase 2b Trial of Intracoronary Administration of AAV1/SERCA2a in Patients With Advanced Heart Failure
- (2014) Barry Greenberg et al. JACC-Heart Failure
- Oxidative stress in cardiomyocytes contributes to decreased SERCA2a activity in rats with metabolic syndrome
- (2013) Jaime Balderas-Villalobos et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Istaroxime stimulates SERCA2a and accelerates calcium cycling in heart failure by relieving phospholamban inhibition
- (2013) Mara Ferrandi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Long-Term Effects of AAV1/SERCA2a Gene Transfer in Patients With Severe Heart Failure
- (2013) Krisztina Zsebo et al. CIRCULATION RESEARCH
- Forecasting the Impact of Heart Failure in the United States
- (2013) Paul A. Heidenreich et al. Circulation-Heart Failure
- Benefit of SERCA2a Gene Transfer to Vascular Endothelial and Smooth Muscle Cells: A New Aspect in Therapy of Cardiovascular Diseases
- (2013) Larissa Lipskaia et al. Current Vascular Pharmacology
- Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys
- (2013) F. Mingozzi et al. Science Translational Medicine
- SUMO-1 Gene Transfer Improves Cardiac Function in a Large-Animal Model of Heart Failure
- (2013) L. Tilemann et al. Science Translational Medicine
- Targeted Sarcoplasmic Reticulum Ca 2+ ATPase 2a Gene Delivery to Restore Electrical Stability in the Failing Heart
- (2012) Michael J. Cutler et al. CIRCULATION
- SERCA2a gene transfer prevents intimal proliferation in an organ culture of human internal mammary artery
- (2012) L Lipskaia et al. GENE THERAPY
- Clinical Trials Update AHA Congress 2010
- (2011) John D. Horowitz et al. CARDIOVASCULAR DRUGS AND THERAPY
- Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID)
- (2011) Mariell Jessup et al. CIRCULATION
- SERCA2a Gene Transfer Decreases Sarcoplasmic Reticulum Calcium Leak and Reduces Ventricular Arrhythmias in a Model of Chronic Heart Failure
- (2011) Alexander R. Lyon et al. Circulation-Arrhythmia and Electrophysiology
- SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice
- (2011) Jin-Hong Shin et al. Journal of Translational Medicine
- Unknown
- (2011) Wei Xin et al. MOLECULAR MEDICINE
- SUMO1-dependent modulation of SERCA2a in heart failure
- (2011) Changwon Kho et al. NATURE
- Cardiac AAV9-S100A1 Gene Therapy Rescues Post-Ischemic Heart Failure in a Preclinical Large Animal Model
- (2011) S. T. Pleger et al. Science Translational Medicine
- Comparative Cardiac Gene Delivery of Adeno-Associated Virus Serotypes 1-9 reveals that AAV6 Mediates the Most Efficient Transduction in Mouse Heart
- (2010) Carmela Zincarelli et al. CTS-Clinical and Translational Science
- SERCA2a Gene Transfer Enhances eNOS Expression and Activity in Endothelial Cells
- (2010) Lahouaria Hadri et al. MOLECULAR THERAPY
- Development of Viral Vectors for Use in Cardiovascular Gene Therapy
- (2010) Paul Williams et al. Viruses-Basel
- Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID Trial), a First-in-Human Phase 1/2 Clinical Trial
- (2009) Brian E. Jaski et al. JOURNAL OF CARDIAC FAILURE
- Design of a Phase 1/2 Trial of Intracoronary Administration of AAV1/SERCA2a in Patients With Heart Failure
- (2008) Roger J. Hajjar et al. JOURNAL OF CARDIAC FAILURE
- Reversal of Cardiac Dysfunction After Long-Term Expression of SERCA2a by Gene Transfer in a Pre-Clinical Model of Heart Failure
- (2008) Yoshiaki Kawase et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lentiviral Vector–mediated SERCA2 Gene Transfer Protects Against Heart Failure and Left Ventricular Remodeling After Myocardial Infarction in Rats
- (2008) Kazuo Niwano et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search